Beranda2359 • HKG
add
WuXi AppTec Ord Shs H
Tutup sebelumnya
$105,20
Rentang hari
$101,00 - $106,10
Rentang tahun
$44,30 - $124,70
Kapitalisasi pasar
292,81 M HKD
Volume Rata-Rata
5,64 jt
Rasio P/E
18,11
Hasil dividen
1,42%
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 12,04 M | 15,14% |
Biaya operasional | 1,38 M | — |
Penghasilan bersih | 3,51 M | — |
Margin laba bersih | 29,18 | — |
Penghasilan per saham | 1,24 | 61,04% |
EBITDA | 5,21 M | — |
Tarif pajak efektif | 30,19% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 33,74 M | 140,13% |
Total aset | 94,61 M | 27,44% |
Total liabilitas | 23,13 M | 24,01% |
Total ekuitas | 71,47 M | — |
Saham yang beredar | 2,87 M | — |
Harga terhadap nilai buku | 4,25 | — |
Tingkat pengembalian aset | 12,87% | — |
Tingkat pengembalian modal | 15,11% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 3,51 M | — |
Kas dari operasi | 3,98 M | — |
Kas dari investasi | -1,40 M | — |
Kas dari pembiayaan | 5,35 M | — |
Perubahan kas bersih | 7,92 M | — |
Arus kas bebas | -1,63 M | — |
Tentang
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. Wikipedia
Didirikan
1 Des 2000
Situs
Karyawan
37.832
